Inaugural Scientific and Clinical Symposium on Pneumonia

Friday, December 9, 2016

7.25 AMA PRA Category 1 CreditsTM


View Syllabus


Pneumonia has been named the forgotten killer. The WHO estimates that lower respiratory tract infection is the most common infectious cause of death in the world with almost 3.5 million deaths yearly. In addition, community-acquired pneumonia (CAP) is responsible for an estimated 10 million deaths annually worldwide. Within the United States alone, pneumococcus is responsible for more than half a million CAP cases each year, with a fatality rate of 5%-7%. Despite advances in the understanding of contributing causes and prevention, hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) continue to be frequent complications of hospital care. HAP and VAP represent up to 22% of all hospital-acquired infections. Statistics point to the need for continued action to accelerate the reduction of morbidity and mortality associated with these lung infections. Furthermore, the increasing incidence of antibiotic resistance stresses the importance of increasing our knowledge of mechanisms that have the potential to influence the outcome of pneumonia. This interactive, discussion-based symposium will provide the audience with relevant information on the currently accepted guidelines as well as the use of newly available tools for the diagnosis and treatment of pneumonia.

The symposium will also have research abstract presentations in the afternoon. To learn more on abstract/poster submissions, please click on the Abstract Submission Information tab.

Friday, December 9, 2016

7.25 AMA PRA Category 1 Credits(TM)



The Anlyan Center for Medical Research and Education

1st Floor Auditorium

300 Cedar Street, New Haven, CT


This course will enable participants to:

  • Review current state of the art concepts in the pathogenesis of pneumonia
  • Discuss current understanding and guidelines for community acquired pneumonia
  • Discuss new guidelines for hospital acquired pneumonia
  • Discuss new guidelines for ventilator-associated pneumonia
  • Determine the utility of new diagnostic tools for determining etiology of the pneumonia
  • Discuss how procalcitonin and other biomarkers can be used in pneumonia management
  • Review new therapies for respiratory infections
  • Highlight new guidelines for antibiotics resistance and stewardship
  • Discuss recent influenza and pneumococcal vaccines


Registration fee* includes continental breakfast, refreshment breaks, and lunch:

Physicians - $125
Nurses/PAs/Allied Health Professionals - $75
Non-Yale Residents/Fellows/Students^ - $50
Yale Residents/Fellows/Students/Postdoctoral Fellows^ - complimentary, registration required

Members of Yale CPIRT Center for Pulmonary Infection Research and Treatment (faculty, researchers) - complimentary, registration required

Yale Full-time Faculty and Staff - complimentary, registration required


*All cancellations must be received in writing (or via e-mail) at least one week prior to the start of the conference to receive a refund. Any requests for refunds received after this date, or by telephone, will not be honored.

^A letter of verification from department head must accompany registration. Letter should be sent separately to Yale CME at the below below. You may also e-mail a pdf copy of your verification letter to


If paying via check, include conference name in the memo, make check payable to Yale University and send to:


Center for Continuing Medical Education

Yale School of Medicine

333 Cedar Street

PO Box 208052

New Haven, CT 06520-8052

Accreditation Statement

The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Designation Statement

The Yale School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits(TM). Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Policy

It is the policy of Yale School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational programs.  All faculty participating as speakers in these programs are required to disclose any relevant financial relationship(s) they (or spouse or partner) have with a commercial interest that benefits the individual in any financial amount that has occurred within the past 12 months; and the opportunity to affect the content of CME about the products or services of the commercial interests.  The Center for Continuing Medical Education will ensure that any conflicts of interest are resolved before the educational activity occurs.